MENU
+Compare
VRTX
Stock ticker: NASDAQ
AS OF
Jun 3, 03:35 PM (EDT)
Price
$448.93
Change
+$3.50 (+0.79%)
Capitalization
114.39B

VRTX Vertex Pharmaceuticals Forecast, Technical & Fundamental Analysis

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases... Show more

Industry: #Biotechnology
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VRTX with price predictions
Jun 02, 2025

VRTX's RSI Indicator recovers from oversold territory

The RSI Oscillator for VRTX moved out of oversold territory on May 15, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 17 similar instances when the indicator left oversold territory. In of the 17 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 21, 2025. You may want to consider a long position or call options on VRTX as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VRTX just turned positive on May 27, 2025. Looking at past instances where VRTX's MACD turned positive, the stock continued to rise in of 55 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VRTX advanced for three days, in of 348 cases, the price rose further within the following month. The odds of a continued upward trend are .

VRTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

VRTX moved below its 50-day moving average on May 06, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VRTX crossed bearishly below the 50-day moving average on May 07, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VRTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VRTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.935) is normal, around the industry mean (17.331). P/E Ratio (32.764) is within average values for comparable stocks, (59.245). Projected Growth (PEG Ratio) (2.653) is also within normal values, averaging (2.227). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (10.341) is also within normal values, averaging (261.682).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VRTX is expected to report earnings to rise 5.91% to $4.30 per share on July 31

Vertex Pharmaceuticals VRTX Stock Earnings Reports
Q2'25
Est.
$4.30
Q1'25
Missed
by $0.20
Q4'24
Missed
by $0.04
Q3'24
Beat
by $0.30
Q2'24
Missed
by $1.13
The last earnings report on May 05 showed earnings per share of $4.06, missing the estimate of $4.26. With 373.83K shares outstanding, the current market capitalization sits at 114.39B.
A.I. Advisor
published General Information

General Information

a company that discovers and develops novel, small molecule pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
50 Northern Avenue
Phone
+1 617 341-6100
Employees
5400
Web
https://www.vrtx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRM24.540.53
+2.21%
Vroom Inc
UUUU4.87-0.02
-0.41%
Energy Fuels
RLGT5.90-0.04
-0.67%
Radiant Logistics
WST209.39-1.46
-0.69%
West Pharmaceutical Services
UMBF102.13-0.99
-0.96%
UMB Financial Corp

VRTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VRTX has been loosely correlated with KRYS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VRTX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRTX
1D Price
Change %
VRTX100%
+0.76%
KRYS - VRTX
48%
Loosely correlated
-0.48%
TECH - VRTX
40%
Loosely correlated
+0.43%
CCCC - VRTX
39%
Loosely correlated
+6.40%
REGN - VRTX
39%
Loosely correlated
+0.11%
SNDX - VRTX
39%
Loosely correlated
+4.17%
More